About Cordis
Cordis is a company based in Fremont (United States) founded in 1957 was acquired by Hellman & Friedman in March 2021. The company has 14 employees as of April 09, 2024. Cordis has completed 3 acquisitions, including Flexible Stenting Solutions, Lumend and MedAlliance. Cordis operates in a competitive market with competitors including TISSIUM, Cardival Medical, Laminate Medical, Aziyo Biologics and Vivasure Medical, among others.
- Headquarter Fremont, United States
- Employees 14 as on 09 Apr, 2024
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Cordis India Medical Devices Private Limited
- Date of Incorporation 29 Mar, 2017
- Jurisdiction Mumbai, Maharashtra, India
-
Annual Revenue
$12 M (USD)36.45as on Mar 31, 2022
-
Net Profit
$442.27 K (USD)1197.07as on Mar 31, 2022
-
EBITDA
$209.13 K (USD)-50.27as on Mar 31, 2022
-
Latest Funding Round
Not available
-
Investors
KKR
& 3 more
-
Employee Count
14
as on Apr 09, 2024
-
Investments & Acquisitions
Flexible Stenting Solutions
& 2 more
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Cordis
Unlock access to complete
Finance and Accounting
21 people
Leadership Team
19 people
Software Development Team
12 people
Human Resources and Administration
10 people
Senior Team
4 people
Operations Team
4 people
Manager Team
2 people
Legal and Compliance
2 people
Unlock access to complete
Funding Insights of Cordis
Detailed funding history for Cordis
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Cordis
Cordis has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include KKR, Cardinal Health and Ajax Health.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Multiple sectors are invested in by this private equity firm.
|
Locked | Locked | Locked | |
|
Private equity firm focused on acquisitions
|
Locked | Locked | Locked | |
|
Multiple healthcare products and services are provided to organizations.
|
Locked | Locked | Locked |
Investor details for Cordis
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Cordis
Cordis has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include Flexible Stenting Solutions, Lumend and MedAlliance.
Investment portfolio details for Cordis
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Developer of drug delivery device for the treatment of coronary and peripheral artery diseases
|
Locked | Locked | 2008 | Locked | |
|
Self-expanding biliary stents are developed for palliative treatment of strictures.
|
Locked | Locked | 2006 | Locked | |
|
Catheter-based technologies for crossing chronic vascular occlusions are developed.
|
Locked | Locked | 1996 | Locked |
Complete acquisition details for Cordis
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Cordis
Detailed financials for Cordis
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cordis Comparisons
Peer comparison for Cordis
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Cordis
Cordis operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as TISSIUM, Cardival Medical, Laminate Medical, Aziyo Biologics and Vivasure Medical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Vascular sealants for open surgery are developed by TISSIUM.
|
|
| Locked | Locked | Locked |
A device for vascular access management is developed.
|
|
| Locked | Locked | Locked |
AV fistula maturation and patency are supported by VasQ device.
|
|
| Locked | Locked | Locked |
Regenerative medicine products are developed for orthopedic and cardiovascular applications.
|
|
| Locked | Locked | Locked |
Bioabsorbable implants and delivery systems for arteriotomy closure are developed.
|
|
| Locked | Locked | Locked |
Ultrasound thrombolytic devices for pulmonary embolism treatment are developed.
|
Detailed competitors of Cordis
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cordis
Complete news archive for Cordis
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cordis
Cordis was founded in 1957.
Cordis is headquartered in Fremont, United States. It is registered at Fremont, California, United States.
Shar Matin is the current CEO of Cordis.
As of Apr 09, 2024, the latest employee count at Cordis is 14.
Annual revenue of Cordis is $12M as on Mar 31, 2022.
Cordis was founded in 1957 and is headquartered in Fremont, United States. Operations focus on the medical device sector, where products including stents, catheters, guidewires, and vena cava filters are manufactured. These items support interventional medicine, minimally invasive imaging, and electrophysiology procedures. Distribution occurs globally through established channels in the cardiovascular field.
Cordis's top competitors include TISSIUM, Vivasure Medical and Rejoni.
Cordis has made 3 acquisitions, including Flexible Stenting Solutions, Lumend, and MedAlliance.
Cordis has 4 investors. Key investors include KKR, Cardinal Health, Ajax Health, and Hellman & Friedman.